Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Roche

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2011
Transcriptional regulation of genes via hypoxia-inducible factorOlga Roche, Michael Ohh
Frontiers in Oncology|June 26, 2018
Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal CancerFlorinda Meléndez-Rodríguez, Olga Roche, Ricardo Sanchez-Prieto, et al.
Molecular Immunology|August 26, 2011
SERPING1 mutations in 59 families with hereditary angioedemaAlberto López-Lera, Sofía Garrido, Olga Roche, et al.
Human Mutation|October 29, 2002
Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutationsAlvaro Blanch, Olga Roche, Eduardo López-Granados, et al.
Human Mutation|June 23, 2005
Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohortOlga Roche, Alvaro Blanch, Christiane Duponchel, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2006
First case of homozygous C1 inhibitor deficiencyAlvaro Blanch, Olga Roche, Ignacio Urrutia, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 7, 2005
Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in SpainOlga Roche, Alvaro Blanch, Teresa Caballero, et al.
Clinical Genitourinary Cancer|June 19, 2017
Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term StudyAntonio S Salinas-Sánchez, Leticia Serrano-Oviedo, Syongh Y Nam-Cha, et al.
Frontiers in Cell and Developmental Biology|July 23, 2016
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryJesús García-Cano, Olga Roche, Francisco J Cimas, et al.
International Journal of Molecular Sciences|October 15, 2020
p38β and Cancer: The Beginning of the RoadOlga Roche, Diego M Fernández-Aroca, Elena Arconada-Luque, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2011
Transcriptional regulation of genes via hypoxia-inducible factorOlga Roche, Michael Ohh
Frontiers in Oncology|June 26, 2018
Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal CancerFlorinda Meléndez-Rodríguez, Olga Roche, Ricardo Sanchez-Prieto, et al.
Molecular Immunology|August 26, 2011
SERPING1 mutations in 59 families with hereditary angioedemaAlberto López-Lera, Sofía Garrido, Olga Roche, et al.
Human Mutation|October 29, 2002
Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutationsAlvaro Blanch, Olga Roche, Eduardo López-Granados, et al.
Human Mutation|June 23, 2005
Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohortOlga Roche, Alvaro Blanch, Christiane Duponchel, et al.
The Journal of Allergy and Clinical Immunology|December 2, 2006
First case of homozygous C1 inhibitor deficiencyAlvaro Blanch, Olga Roche, Ignacio Urrutia, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 7, 2005
Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in SpainOlga Roche, Alvaro Blanch, Teresa Caballero, et al.
Clinical Genitourinary Cancer|June 19, 2017
Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term StudyAntonio S Salinas-Sánchez, Leticia Serrano-Oviedo, Syongh Y Nam-Cha, et al.
Frontiers in Cell and Developmental Biology|July 23, 2016
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryJesús García-Cano, Olga Roche, Francisco J Cimas, et al.
International Journal of Molecular Sciences|October 15, 2020
p38β and Cancer: The Beginning of the RoadOlga Roche, Diego M Fernández-Aroca, Elena Arconada-Luque, et al.
Pageof 3